Bacteriological Study of Acute Follicular Tonsillitis
1 other identifier
observational
66
0 countries
N/A
Brief Summary
The objective of the study is to answer the following questions :-
- 1.Is there an actual failure rate in tonsillitis treatment with amoxicillin clavulanate ? If yes,
- 2.What is (are) the possible reason(s) to explain it in our locality ?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 19, 2020
CompletedFirst Posted
Study publicly available on registry
March 25, 2020
CompletedStudy Start
First participant enrolled
April 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2021
CompletedMarch 25, 2020
March 1, 2020
1 year
March 19, 2020
March 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
The sensitivity of the isolated organism to amoxicillin clavulanate according to culture and sensitivity test
throat swabs that will be taken from the tonsillar exudate, placed in sterile bottles and brought to the laboratory for Bacteriological culture of the organism and Antibiotic sensitivity tests will be done for the isolated organism(s).
Baseline
Interventions
Intravenous drug intake of our drug.
Eligibility Criteria
Patients with acute follicular tonsillitis
You may qualify if:
- patients with acute follicular tonsillitis neither younger than five years nor older than 60 years old.
You may not qualify if:
- Other causes of tonsillitis that do not cause suppuration .
- Age below five , and above 60 years .
- Patients who received antibiotic one week before presentation .
- Immune compromised patients .
- Patients with quinsy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Brook I. Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis. Int J Pediatr Otorhinolaryngol. 2007 Oct;71(10):1501-8. doi: 10.1016/j.ijporl.2007.06.006. Epub 2007 Jul 17.
PMID: 17644191BACKGROUNDCasey JR, Pichichero ME. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis. Diagn Microbiol Infect Dis. 2007 Mar;57(3 Suppl):39S-45S. doi: 10.1016/j.diagmicrobio.2006.12.020. Epub 2007 Feb 9.
PMID: 17292576BACKGROUNDSela S, Barzilai A. Why do we fail with penicillin in the treatment of group A streptococcus infections? Ann Med. 1999 Oct;31(5):303-7. doi: 10.3109/07853899908995895.
PMID: 10574501BACKGROUND
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 19, 2020
First Posted
March 25, 2020
Study Start
April 1, 2020
Primary Completion
April 1, 2021
Study Completion
October 1, 2021
Last Updated
March 25, 2020
Record last verified: 2020-03